Influenza Vaccine Market Research Report 2012-2024
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Trivalent Influenza Vaccine
- 1.2.1.2 Quadrivalent Influenza Vaccine
- 1.2.1.3 Others
- 1.2.2 by Application
- 1.2.2.1 Children
- 1.2.2.2 Adults
- 1.2.2.3 Elderly
- 1.2.2.4 Pregnancy
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Trivalent Influenza Vaccine Market, 2013-2018
- 4.1.2 Quadrivalent Influenza Vaccine Market, 2013-2018
- 4.1.3 Others Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Trivalent Influenza Vaccine Market Forecast, 2019-2024
- 4.2.2 Quadrivalent Influenza Vaccine Market Forecast, 2019-2024
- 4.2.3 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Children Market, 2013-2018
- 5.1.2 Adults Market, 2013-2018
- 5.1.3 Elderly Market, 2013-2018
- 5.1.4 Pregnancy Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Children Market Forecast, 2019-2024
- 5.2.2 Adults Market Forecast, 2019-2024
- 5.2.3 Elderly Market Forecast, 2019-2024
- 5.2.4 Pregnancy Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 GSK
- 8.2 Sinovac
- 8.3 Changsheng
- 8.4 CCBIO
- 8.5 Aleph Biomedical
- 8.6 Sanofi
- 8.7 Lanzhou Institute Of Biological Product
- 8.8 Siobp
- 8.9 Hualan Bio
- 8.10 Tianyuan Bio-Pharma
- 8.11 Vaxtec
- 8.12 Hissen
- 8.13 Abbott
- 8.14 Novartis
- 8.15 Tasly&Jenner
- 8.16 Tiantan
9 Conclusion
Summary
The Influenza Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Children
Adults
Elderly
Pregnancy
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa